The company has chosen to move ahead to Phase III trials with its 10mg dose after it saw a 1.74-point reduction in pain score ...

Despite not differentiating itself from placebo, the Texas-based company said it plans to push pilavapadin into Phase III ...

Lexicon Pharmaceuticals is yet again defending a mixed set of data on its non-opioid pain prospect. | Lexicon Pharmaceuticals ...

Lexicon's non-opioid drug pilavapadin fails Phase 2b pain trial at 20mg dose, but shows promise at 10mg. Company plans Phase ...

Sudafed, Mucinex, Benadryl, Advil, Tylenol, Vicks, and Dimetapp. These popular brand names appear on oral decongestants that ...

Pharmsynthez, one of Russia’s largest drugmakers, will build a large-scale plant for the production of anticancer drugs in the city of Moscow by 2026. Under the terms of the project, the new plant ...

The younger Gen Z (35%) was most likely to prefer brand-name drugs—despite being an average 79% more expensive. Tebra, a tech firm whose software supports more than 100,000 independent health ...

Here are some troubling “highlights” from the UN’s latest World Drugs Report: Cocaine production is reaching record highs, with production climbing in Latin America coupled with drug use and ...

Travis Kelce will come full circle next weekend in New Orleans - 15 years after wild Louisiana parties and a failed drugs test once threatened to derail his football career. After getting past the ...